Literature DB >> 1863899

The significance of specific IgG and IgG4 antibodies to a reactive dye in exposed workers.

H S Park1, C S Hong.   

Abstract

To evaluate the significance of specific IgG and specific IgG4 in the development of work-related respiratory symptoms, specific IgG and specific IgG4 to Black GR-human serum albumin (HSA) conjugate were measured by ELISA in 309 dye-exposed workers and 63 unexposed patients as negative controls. A survey revealed that 78 (25.2%) had work-related lower respiratory symptoms with or without nasal, skin or eye symptoms. Specific IgG and specific IgG4 were detected in 23% and 14% of the exposed workers, respectively. The prevalence of specific IgG and specific IgG4 was significantly higher in smokers and workers with specific IgE or those with lower respiratory symptoms (P less than 0.05), but was not associated with work station, duration of dye exposure or atopy. These results suggested that the existence of specific IgG to Black GR-HSA might represent a response to Black GR exposure and be closely related with work-related respiratory symptoms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1863899     DOI: 10.1111/j.1365-2222.1991.tb01668.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  3 in total

Review 1.  Cell and molecular biology of chemical allergy.

Authors:  I Kimber; R J Dearman
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

2.  Cork workers' occupational asthma: lack of association with allergic sensitisation to fungi of the work environment.

Authors:  João C Winck; Luís Delgado; Rita Murta; Manuela Vanzeller; J Agostinho Marques
Journal:  Int Arch Occup Environ Health       Date:  2004-01-22       Impact factor: 3.015

3.  Role of specific IgE, IgG and IgG4 antibodies to corn dust in exposed workers.

Authors:  H S Park; D H Nahm; H Y Kim; C H Suh; K S Kim
Journal:  Korean J Intern Med       Date:  1998-07       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.